{'fraction_non_alphanumeric': 0.01856763925729443, 'fraction_numerical': 0.0, 'mean_word_length': 5.138211382113822, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Research Progress in Drug Therapy of Diabetic Peripheral Neuropathy

: Diabetic peripheral neuropathy has a serious impact on the health and quality of life of patients. At present, the disease is mainly treated by aldose reductase inhibitors and other drugs. These drugs can effectively relieve the clinical symptoms of patients, and have good improvement effect on their neurological function, which can delay the development of the disease to a large extent. In clinical treatment, for the treatment of the disease, mainly in the premise of stable control of blood sugar, give patients the corresponding drug adjuvant treatment. In this paper, on the basis of consulting the relevant literature, we analyzed the progress of drug treatment of patients.